Clinical trial
Single or Combined Protocols for the Treatment of Patients With Neovascular Age-related Macular Degeneration: Compliance, Risk/Benefit and Cost/Benefit Ratios
NCT03552770 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single or Combined Protocols for the Treatment of Patients With Neovascular Age-related Macular Degeneration: Compliance, Risk/Benefit and Cost/Benefit Ratios
- Lead sponsor
- University Hospital of Ferrara
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 23, 2014
- Completion date
- December 29, 2016
- Enrollment
- 109 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration